Oncology Expert Witness

Oncology expert witnesses evaluate cancer staging, treatment protocol selection, chemotherapy dosing and toxicity monitoring, radiation planning, and the informed consent process for experimental and standard regimens. They interpret pathology, tumor markers, imaging response, and genomic testing to determine whether the treatment plan and its execution met NCCN guidelines and institutional standards for the cancer type and stage at diagnosis.

Cases commonly requiring oncology expertise include delayed cancer diagnosis resulting in stage progression and reduced survival, chemotherapy dosing errors causing organ toxicity or death, failure to refer to appropriate subspecialty oncology, radiation treatment planning errors, and informed consent disputes around clinical trials versus standard therapy. These cases often involve complex causation analysis linking the delay or error to quantifiable loss of survival probability.

Subspecialties including breast oncology, thoracic oncology, GI oncology, genitourinary oncology, neuro-oncology, and hematologic malignancies each follow distinct treatment algorithms and clinical trial landscapes. An expert actively treating the specific cancer type provides opinions grounded in current practice patterns rather than outdated regimens that no longer represent standard of care.